Interestingly, CD74 expression in tumor cells was not associated with clinical parameters such as Karnofsky Performance Status (KPS) or in case of melanoma the Graded Prognostic Assessment (GPA) Score (Additional file 1: Figure S1). This evidence concerns the gene CD74 and neoplasm.